nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—Quinacrine—PLCL1—Crohn's disease	0.0382	0.906	CrCbGaD
Hydroxychloroquine—Reaction gastrointestinal—Azathioprine—Crohn's disease	0.0146	0.0367	CcSEcCtD
Hydroxychloroquine—Bone marrow depression—Mercaptopurine—Crohn's disease	0.0121	0.0305	CcSEcCtD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD1—Crohn's disease	0.0112	0.02	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—NOD1—Crohn's disease	0.011	0.0196	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—NOD1—Crohn's disease	0.0106	0.0189	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD1—Crohn's disease	0.00886	0.0158	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—NOD1—Crohn's disease	0.0087	0.0155	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—NOD1—Crohn's disease	0.00839	0.015	CbGpPWpGaD
Hydroxychloroquine—Hepatocellular injury—Mercaptopurine—Crohn's disease	0.00816	0.0206	CcSEcCtD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RIPK2—Crohn's disease	0.00783	0.0139	CbGpPWpGaD
Hydroxychloroquine—Foetor hepaticus—Mesalazine—Crohn's disease	0.00781	0.0197	CcSEcCtD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—RIPK2—Crohn's disease	0.00768	0.0137	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—NOD1—Crohn's disease	0.00755	0.0134	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—RIPK2—Crohn's disease	0.00741	0.0132	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TAB1—Crohn's disease	0.00722	0.0129	CbGpPWpGaD
Hydroxychloroquine—Bone marrow depression—Azathioprine—Crohn's disease	0.0072	0.0182	CcSEcCtD
Hydroxychloroquine—Atrophy—Prednisone—Crohn's disease	0.00719	0.0181	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL12B—Crohn's disease	0.00716	0.0128	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—Crohn's disease	0.00709	0.0126	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—TAB1—Crohn's disease	0.00709	0.0126	CbGpPWpGaD
Hydroxychloroquine—Psoriasis—Mesalazine—Crohn's disease	0.00705	0.0178	CcSEcCtD
Hydroxychloroquine—Pigmentation disorder—Prednisone—Crohn's disease	0.00702	0.0177	CcSEcCtD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—NOD2—Crohn's disease	0.00697	0.0124	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—TAB1—Crohn's disease	0.00684	0.0122	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—NOD2—Crohn's disease	0.00672	0.012	CbGpPWpGaD
Hydroxychloroquine—Bone marrow depression—Mesalazine—Crohn's disease	0.00656	0.0165	CcSEcCtD
Hydroxychloroquine—Abdominal cramps—Mesalazine—Crohn's disease	0.00656	0.0165	CcSEcCtD
Hydroxychloroquine—Liver disorder—Mesalazine—Crohn's disease	0.0065	0.0164	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TAB1—Crohn's disease	0.0063	0.0112	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RIPK2—Crohn's disease	0.00619	0.011	CbGpPWpGaD
Hydroxychloroquine—Throat sore—Mesalazine—Crohn's disease	0.00615	0.0155	CcSEcCtD
Hydroxychloroquine—Oropharyngeal discomfort—Mesalazine—Crohn's disease	0.00609	0.0154	CcSEcCtD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—RIPK2—Crohn's disease	0.00607	0.0108	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—NOD1—Crohn's disease	0.00596	0.0106	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—RIPK2—Crohn's disease	0.00586	0.0104	CbGpPWpGaD
Hydroxychloroquine—Scotoma—Mesalazine—Crohn's disease	0.00583	0.0147	CcSEcCtD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TAB1—Crohn's disease	0.00571	0.0102	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL12B—Crohn's disease	0.00566	0.0101	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—Crohn's disease	0.00561	0.00999	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—TAB1—Crohn's disease	0.0056	0.00999	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL12B—Crohn's disease	0.00559	0.00996	CbGpPWpGaD
Hydroxychloroquine—Leukoderma—Prednisone—Crohn's disease	0.00551	0.0139	CcSEcCtD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—NOD2—Crohn's disease	0.00551	0.00981	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—UBE2D1—Crohn's disease	0.00543	0.00968	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—TAB1—Crohn's disease	0.00541	0.00964	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—NOD2—Crohn's disease	0.00531	0.00947	CbGpPWpGaD
Hydroxychloroquine—Blood disorder—Mesalazine—Crohn's disease	0.0053	0.0134	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—RIPK2—Crohn's disease	0.00527	0.00939	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TAB1—Crohn's disease	0.00498	0.00888	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TAB1—Crohn's disease	0.00492	0.00877	CbGpPWpGaD
Hydroxychloroquine—Skin discolouration—Mesalazine—Crohn's disease	0.0049	0.0124	CcSEcCtD
Hydroxychloroquine—Oropharyngeal pain—Mesalazine—Crohn's disease	0.00487	0.0123	CcSEcCtD
Hydroxychloroquine—Hepatocellular injury—Azathioprine—Crohn's disease	0.00486	0.0123	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Mercaptopurine—Crohn's disease	0.00486	0.0123	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—TAB1—Crohn's disease	0.00486	0.00867	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—NOD2—Crohn's disease	0.00478	0.00851	CbGpPWpGaD
Hydroxychloroquine—Aplastic anaemia—Azathioprine—Crohn's disease	0.00457	0.0115	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—SOCS1—Crohn's disease	0.00455	0.00812	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—SOCS1—Crohn's disease	0.0045	0.00802	CbGpPWpGaD
Hydroxychloroquine—Hepatocellular injury—Mesalazine—Crohn's disease	0.00443	0.0112	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL12B—Crohn's disease	0.00442	0.00787	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—UBE2D1—Crohn's disease	0.0043	0.00766	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TLR4—Crohn's disease	0.00422	0.00752	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—RIPK2—Crohn's disease	0.00416	0.00742	CbGpPWpGaD
Hydroxychloroquine—Aplastic anaemia—Mesalazine—Crohn's disease	0.00416	0.0105	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—DEFA5—Crohn's disease	0.00411	0.00733	CbGpPWpGaD
Hydroxychloroquine—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00404	0.0102	CcSEcCtD
Hydroxychloroquine—Chloroquine—TNF—Crohn's disease	0.00398	0.0944	CrCbGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TAB1—Crohn's disease	0.00389	0.00693	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—TAB1—Crohn's disease	0.00384	0.00685	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—NOD2—Crohn's disease	0.00378	0.00673	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TYK2—Crohn's disease	0.00377	0.00671	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ERAP2—Crohn's disease	0.00371	0.00662	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—TYK2—Crohn's disease	0.0037	0.00659	CbGpPWpGaD
Hydroxychloroquine—Photosensitivity—Mesalazine—Crohn's disease	0.00366	0.00923	CcSEcCtD
Hydroxychloroquine—Alopecia—Mercaptopurine—Crohn's disease	0.00362	0.00913	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—SOCS1—Crohn's disease	0.0036	0.00642	CbGpPWpGaD
Hydroxychloroquine—Deafness—Mesalazine—Crohn's disease	0.00359	0.00906	CcSEcCtD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JAK2—Crohn's disease	0.00359	0.0064	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—TYK2—Crohn's disease	0.00357	0.00636	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Mercaptopurine—Crohn's disease	0.00357	0.00899	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—SOCS1—Crohn's disease	0.00356	0.00634	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—JAK2—Crohn's disease	0.00353	0.00629	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—JAK2—Crohn's disease	0.0034	0.00607	CbGpPWpGaD
Hydroxychloroquine—Dermatitis bullous—Mesalazine—Crohn's disease	0.00336	0.00848	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CARD9—Crohn's disease	0.00335	0.00597	CbGpPWpGaD
Hydroxychloroquine—Myopathy—Prednisone—Crohn's disease	0.00334	0.00842	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TLR4—Crohn's disease	0.00333	0.00594	CbGpPWpGaD
Hydroxychloroquine—Anaemia—Mercaptopurine—Crohn's disease	0.0033	0.00831	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TLR4—Crohn's disease	0.00329	0.00587	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—TLR4—Crohn's disease	0.00326	0.0058	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—DEFA5—Crohn's disease	0.00325	0.00579	CbGpPWpGaD
Hydroxychloroquine—Leukopenia—Mercaptopurine—Crohn's disease	0.00319	0.00805	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.00318	0.00801	CcSEcCtD
Hydroxychloroquine—Affect lability—Mesalazine—Crohn's disease	0.00317	0.00798	CcSEcCtD
Hydroxychloroquine—Mood swings—Mesalazine—Crohn's disease	0.00305	0.00768	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00302	0.0076	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—TYK2—Crohn's disease	0.00301	0.00536	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TYK2—Crohn's disease	0.00298	0.00531	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MADCAM1—Crohn's disease	0.00297	0.00529	CbGpPWpGaD
Hydroxychloroquine—Liver function test abnormal—Mesalazine—Crohn's disease	0.00297	0.00748	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Mesalazine—Crohn's disease	0.00294	0.0074	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—ERAP2—Crohn's disease	0.00294	0.00523	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—TYK2—Crohn's disease	0.00292	0.00521	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—TYK2—Crohn's disease	0.00292	0.00521	CbGpPWpGaD
Hydroxychloroquine—Oedema—Mercaptopurine—Crohn's disease	0.00291	0.00734	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Azathioprine—Crohn's disease	0.0029	0.0073	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—TYK2—Crohn's disease	0.0029	0.00516	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—JAK2—Crohn's disease	0.00287	0.00511	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—CXCL8—Crohn's disease	0.00286	0.0051	CbGpPWpGaD
Hydroxychloroquine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00285	0.00719	CcSEcCtD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JAK2—Crohn's disease	0.00284	0.00506	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Mercaptopurine—Crohn's disease	0.00283	0.00713	CcSEcCtD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—TYK2—Crohn's disease	0.00282	0.00503	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—TYK2—Crohn's disease	0.00282	0.00503	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—TYK2—Crohn's disease	0.00282	0.00503	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—JAK2—Crohn's disease	0.00279	0.00497	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—JAK2—Crohn's disease	0.00279	0.00497	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Mercaptopurine—Crohn's disease	0.00278	0.007	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—JAK2—Crohn's disease	0.00276	0.00493	CbGpPWpGaD
Hydroxychloroquine—Eosinophilia—Mesalazine—Crohn's disease	0.00275	0.00694	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL1B—Crohn's disease	0.00274	0.00489	CbGpPWpGaD
Hydroxychloroquine—Bronchospasm—Mesalazine—Crohn's disease	0.00273	0.00689	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.0027	0.0068	CcSEcCtD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—JAK2—Crohn's disease	0.00269	0.0048	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—JAK2—Crohn's disease	0.00269	0.0048	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—JAK2—Crohn's disease	0.00269	0.0048	CbGpPWpGaD
Hydroxychloroquine—Contusion—Prednisone—Crohn's disease	0.00269	0.00677	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—ICOSLG—Crohn's disease	0.00269	0.00479	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CARD9—Crohn's disease	0.00265	0.00472	CbGpPWpGaD
Hydroxychloroquine—Pancytopenia—Mesalazine—Crohn's disease	0.00264	0.00665	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TLR4—Crohn's disease	0.0026	0.00464	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—TLR4—Crohn's disease	0.00257	0.00459	CbGpPWpGaD
Hydroxychloroquine—Agranulocytosis—Azathioprine—Crohn's disease	0.00254	0.0064	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00254	0.00639	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—TYK2—Crohn's disease	0.00254	0.00452	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00253	0.00638	CcSEcCtD
Hydroxychloroquine—Weight decreased—Mesalazine—Crohn's disease	0.00251	0.00634	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00251	0.00634	CcSEcCtD
Hydroxychloroquine—Depression—Mesalazine—Crohn's disease	0.00247	0.00623	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00246	0.00619	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Azathioprine—Crohn's disease	0.00245	0.00619	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—NOD1—Crohn's disease	0.00244	0.00436	CbGpPWpGaD
Hydroxychloroquine—Haemorrhage—Azathioprine—Crohn's disease	0.00244	0.00616	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—JAK2—Crohn's disease	0.00242	0.00431	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IFNGR2—Crohn's disease	0.00239	0.00427	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—DEFA5—Crohn's disease	0.00239	0.00427	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MADCAM1—Crohn's disease	0.00235	0.00418	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—TYK2—Crohn's disease	0.00234	0.00418	CbGpPWpGaD
Hydroxychloroquine—Agranulocytosis—Mesalazine—Crohn's disease	0.00231	0.00583	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Azathioprine—Crohn's disease	0.00231	0.00582	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Mercaptopurine—Crohn's disease	0.0023	0.0058	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—CXCL8—Crohn's disease	0.00226	0.00403	CbGpPWpGaD
Hydroxychloroquine—Haemoglobin—Mesalazine—Crohn's disease	0.00224	0.00564	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—JAK2—Crohn's disease	0.00224	0.00398	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—CXCL8—Crohn's disease	0.00223	0.00398	CbGpPWpGaD
Hydroxychloroquine—Haemorrhage—Mesalazine—Crohn's disease	0.00222	0.00561	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CCR6—Crohn's disease	0.00222	0.00396	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL1B—Crohn's disease	0.00217	0.00387	CbGpPWpGaD
Hydroxychloroquine—Alopecia—Azathioprine—Crohn's disease	0.00216	0.00544	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00215	0.00541	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL1B—Crohn's disease	0.00214	0.00382	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ICOSLG—Crohn's disease	0.00212	0.00378	CbGpPWpGaD
Hydroxychloroquine—Erythema multiforme—Mesalazine—Crohn's disease	0.0021	0.0053	CcSEcCtD
Hydroxychloroquine—Eye disorder—Mesalazine—Crohn's disease	0.00208	0.00524	CcSEcCtD
Hydroxychloroquine—Tinnitus—Mesalazine—Crohn's disease	0.00207	0.00523	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—TYK2—Crohn's disease	0.002	0.00357	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00199	0.00502	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TNF—Crohn's disease	0.00199	0.00355	CbGpPWpGaD
Hydroxychloroquine—Alopecia—Mesalazine—Crohn's disease	0.00197	0.00496	CcSEcCtD
Hydroxychloroquine—Anaemia—Azathioprine—Crohn's disease	0.00196	0.00495	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CARD9—Crohn's disease	0.00195	0.00348	CbGpPWpGaD
Hydroxychloroquine—Mental disorder—Mesalazine—Crohn's disease	0.00195	0.00491	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—NOD1—Crohn's disease	0.00193	0.00344	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—JAK2—Crohn's disease	0.00191	0.00341	CbGpPWpGaD
Hydroxychloroquine—Leukopenia—Azathioprine—Crohn's disease	0.0019	0.0048	CcSEcCtD
Hydroxychloroquine—Tension—Mesalazine—Crohn's disease	0.0019	0.00479	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—DEFA5—Crohn's disease	0.00189	0.00337	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IFNGR2—Crohn's disease	0.00189	0.00337	CbGpPWpGaD
Hydroxychloroquine—Nervousness—Mesalazine—Crohn's disease	0.00188	0.00474	CcSEcCtD
Hydroxychloroquine—Vomiting—Mercaptopurine—Crohn's disease	0.00185	0.00467	CcSEcCtD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Crohn's disease	0.00184	0.00328	CbGpPWpGaD
Hydroxychloroquine—Rash—Mercaptopurine—Crohn's disease	0.00184	0.00463	CcSEcCtD
Hydroxychloroquine—Dermatitis—Mercaptopurine—Crohn's disease	0.00183	0.00462	CcSEcCtD
Hydroxychloroquine—Vision blurred—Mesalazine—Crohn's disease	0.00183	0.0046	CcSEcCtD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—IL6—Crohn's disease	0.00181	0.00322	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.0018	0.00453	CcSEcCtD
Hydroxychloroquine—Anaemia—Mesalazine—Crohn's disease	0.00179	0.00451	CcSEcCtD
Hydroxychloroquine—Angioedema—Mesalazine—Crohn's disease	0.00177	0.00446	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CXCL8—Crohn's disease	0.00177	0.00315	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—UBE2D1—Crohn's disease	0.00176	0.00314	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CCR6—Crohn's disease	0.00175	0.00313	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—Crohn's disease	0.00175	0.00311	CbGpPWpGaD
Hydroxychloroquine—Cardiac failure—Prednisone—Crohn's disease	0.00174	0.00439	CcSEcCtD
Hydroxychloroquine—Vertigo—Mesalazine—Crohn's disease	0.00174	0.00439	CcSEcCtD
Hydroxychloroquine—Leukopenia—Mesalazine—Crohn's disease	0.00173	0.00437	CcSEcCtD
Hydroxychloroquine—Nausea—Mercaptopurine—Crohn's disease	0.00173	0.00436	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—RIPK2—Crohn's disease	0.00171	0.00304	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Mesalazine—Crohn's disease	0.0017	0.00429	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Azathioprine—Crohn's disease	0.0017	0.00428	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL1B—Crohn's disease	0.00169	0.00302	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Azathioprine—Crohn's disease	0.00169	0.00425	CcSEcCtD
Hydroxychloroquine—Affect lability—Prednisone—Crohn's disease	0.00167	0.00422	CcSEcCtD
Hydroxychloroquine—Psychotic disorder—Prednisone—Crohn's disease	0.00166	0.00419	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00164	0.00413	CcSEcCtD
Hydroxychloroquine—Irritability—Prednisone—Crohn's disease	0.00162	0.00409	CcSEcCtD
Hydroxychloroquine—Mood swings—Prednisone—Crohn's disease	0.00161	0.00406	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—RASGRP1—Crohn's disease	0.00161	0.00287	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	0.00161	0.00286	CbGpPWpGaD
Hydroxychloroquine—Oedema—Mesalazine—Crohn's disease	0.00158	0.00398	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—TAB1—Crohn's disease	0.00158	0.00281	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—Crohn's disease	0.00157	0.00281	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TNF—Crohn's disease	0.00155	0.00277	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Mesalazine—Crohn's disease	0.00155	0.00391	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Mesalazine—Crohn's disease	0.00155	0.0039	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—NOD2—Crohn's disease	0.00155	0.00276	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CARD9—Crohn's disease	0.00154	0.00275	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Mesalazine—Crohn's disease	0.00154	0.00387	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—ACKR2—Crohn's disease	0.00152	0.00271	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Mesalazine—Crohn's disease	0.00151	0.0038	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Prednisone—Crohn's disease	0.0015	0.00378	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.0015	0.00378	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—IL6—Crohn's disease	0.00147	0.00262	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—SOCS1—Crohn's disease	0.00146	0.0026	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Crohn's disease	0.00146	0.0026	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MLN—Crohn's disease	0.00144	0.00256	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—IL6—Crohn's disease	0.00143	0.00255	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—IL6—Crohn's disease	0.00143	0.00255	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—NOD1—Crohn's disease	0.00142	0.00254	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00142	0.00358	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IL6—Crohn's disease	0.00142	0.00252	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Mesalazine—Crohn's disease	0.00141	0.00354	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—UBE2D1—Crohn's disease	0.00139	0.00248	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—IL6—Crohn's disease	0.00138	0.00246	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IL6—Crohn's disease	0.00138	0.00246	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—IL6—Crohn's disease	0.00138	0.00246	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Mesalazine—Crohn's disease	0.00137	0.00346	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Azathioprine—Crohn's disease	0.00137	0.00346	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Azathioprine—Crohn's disease	0.00137	0.00346	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00136	0.00344	CcSEcCtD
Hydroxychloroquine—Fatigue—Mesalazine—Crohn's disease	0.00136	0.00343	CcSEcCtD
Hydroxychloroquine—Pain—Mesalazine—Crohn's disease	0.00135	0.00341	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—RIPK2—Crohn's disease	0.00135	0.0024	CbGpPWpGaD
Hydroxychloroquine—Weight decreased—Prednisone—Crohn's disease	0.00133	0.00335	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—TAGAP—Crohn's disease	0.00132	0.00235	CbGpPWpGaD
Hydroxychloroquine—Depression—Prednisone—Crohn's disease	0.00131	0.0033	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CCR6—Crohn's disease	0.00129	0.0023	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00129	0.00326	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Azathioprine—Crohn's disease	0.00128	0.00322	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—RASGRP1—Crohn's disease	0.00127	0.00227	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	0.00127	0.00226	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Mesalazine—Crohn's disease	0.00126	0.00316	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	0.00125	0.00224	CbGpPWpGaD
Hydroxychloroquine—Abdominal pain—Mesalazine—Crohn's disease	0.00125	0.00315	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Mesalazine—Crohn's disease	0.00125	0.00315	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—TAB1—Crohn's disease	0.00125	0.00222	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—IL6—Crohn's disease	0.00124	0.00221	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—Crohn's disease	0.00123	0.00219	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—NOD2—Crohn's disease	0.00122	0.00218	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Azathioprine—Crohn's disease	0.00119	0.00299	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Prednisone—Crohn's disease	0.00118	0.00298	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PTPN2—Crohn's disease	0.00118	0.00211	CbGpPWpGaD
Hydroxychloroquine—Haemorrhage—Prednisone—Crohn's disease	0.00118	0.00297	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—RBX1—Crohn's disease	0.00117	0.00208	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Mesalazine—Crohn's disease	0.00116	0.00294	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—SOCS1—Crohn's disease	0.00115	0.00205	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—RSPO3—Crohn's disease	0.00115	0.00205	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Azathioprine—Crohn's disease	0.00115	0.00289	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—IL6—Crohn's disease	0.00115	0.00204	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Mesalazine—Crohn's disease	0.00113	0.00286	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—NOD1—Crohn's disease	0.00113	0.00201	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Mesalazine—Crohn's disease	0.00112	0.00282	CcSEcCtD
Hydroxychloroquine—Vomiting—Azathioprine—Crohn's disease	0.0011	0.00278	CcSEcCtD
Hydroxychloroquine—Eye disorder—Prednisone—Crohn's disease	0.0011	0.00277	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CRP—Crohn's disease	0.0011	0.00196	CbGpPWpGaD
Hydroxychloroquine—Rash—Azathioprine—Crohn's disease	0.00109	0.00276	CcSEcCtD
Hydroxychloroquine—Dermatitis—Azathioprine—Crohn's disease	0.00109	0.00276	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—SEL1L—Crohn's disease	0.00109	0.00194	CbGpPWpGaD
Hydroxychloroquine—Headache—Azathioprine—Crohn's disease	0.00109	0.00274	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Mesalazine—Crohn's disease	0.00108	0.00273	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—TLR4—Crohn's disease	0.00105	0.00188	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Mesalazine—Crohn's disease	0.00105	0.00263	CcSEcCtD
Hydroxychloroquine—Alopecia—Prednisone—Crohn's disease	0.00104	0.00262	CcSEcCtD
Hydroxychloroquine—Mental disorder—Prednisone—Crohn's disease	0.00103	0.0026	CcSEcCtD
Hydroxychloroquine—Nausea—Azathioprine—Crohn's disease	0.00103	0.0026	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—UBE2D1—Crohn's disease	0.00103	0.00183	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Prednisone—Crohn's disease	0.00102	0.00258	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CCR6—Crohn's disease	0.00102	0.00182	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Mesalazine—Crohn's disease	0.001	0.00253	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CCR9—Crohn's disease	0.000997	0.00178	CbGpPWpGaD
Hydroxychloroquine—Rash—Mesalazine—Crohn's disease	0.000997	0.00251	CcSEcCtD
Hydroxychloroquine—Dermatitis—Mesalazine—Crohn's disease	0.000996	0.00251	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—RIPK2—Crohn's disease	0.000994	0.00177	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ITGA4—Crohn's disease	0.000994	0.00177	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	0.000992	0.00177	CbGpPWpGaD
Hydroxychloroquine—Headache—Mesalazine—Crohn's disease	0.00099	0.0025	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—IL6—Crohn's disease	0.00098	0.00175	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL3—Crohn's disease	0.000969	0.00173	CbGpPWpGaD
Hydroxychloroquine—Vision blurred—Prednisone—Crohn's disease	0.000966	0.00243	CcSEcCtD
Hydroxychloroquine—Anaemia—Prednisone—Crohn's disease	0.000947	0.00239	CcSEcCtD
Hydroxychloroquine—Agitation—Prednisone—Crohn's disease	0.000942	0.00237	CcSEcCtD
Hydroxychloroquine—Nausea—Mesalazine—Crohn's disease	0.000939	0.00237	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—RASGRP1—Crohn's disease	0.000938	0.00167	CbGpPWpGaD
Hydroxychloroquine—Angioedema—Prednisone—Crohn's disease	0.000936	0.00236	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CD79A—Crohn's disease	0.000935	0.00167	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PTPN2—Crohn's disease	0.000935	0.00167	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GPR65—Crohn's disease	0.000927	0.00165	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—RBX1—Crohn's disease	0.000924	0.00165	CbGpPWpGaD
Hydroxychloroquine—Vertigo—Prednisone—Crohn's disease	0.000921	0.00232	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—TAB1—Crohn's disease	0.000917	0.00164	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—NOD2—Crohn's disease	0.000901	0.00161	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Prednisone—Crohn's disease	0.000901	0.00227	CcSEcCtD
Hydroxychloroquine—Convulsion—Prednisone—Crohn's disease	0.000888	0.00224	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CRP—Crohn's disease	0.000869	0.00155	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000866	0.00218	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—SOCS1—Crohn's disease	0.000849	0.00151	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000847	0.00151	CbGpPWpGaD
Hydroxychloroquine—Oedema—Prednisone—Crohn's disease	0.000836	0.00211	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—TLR4—Crohn's disease	0.000833	0.00149	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—TYK2—Crohn's disease	0.000821	0.00146	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Prednisone—Crohn's disease	0.00082	0.00207	CcSEcCtD
Hydroxychloroquine—Skin disorder—Prednisone—Crohn's disease	0.000812	0.00205	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—UBE2D1—Crohn's disease	0.00081	0.00144	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Prednisone—Crohn's disease	0.000797	0.00201	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—RIPK2—Crohn's disease	0.000786	0.0014	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ITGA4—Crohn's disease	0.000786	0.0014	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—JAK2—Crohn's disease	0.000784	0.0014	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL3—Crohn's disease	0.000766	0.00137	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL18—Crohn's disease	0.000765	0.00136	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CD4—Crohn's disease	0.000743	0.00132	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—RASGRP1—Crohn's disease	0.000741	0.00132	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD79A—Crohn's disease	0.000739	0.00132	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Prednisone—Crohn's disease	0.000727	0.00183	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—TAB1—Crohn's disease	0.000725	0.00129	CbGpPWpGaD
Hydroxychloroquine—Fatigue—Prednisone—Crohn's disease	0.000721	0.00182	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—NOD2—Crohn's disease	0.000712	0.00127	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000684	0.00172	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IL2RA—Crohn's disease	0.000679	0.00121	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—SOCS1—Crohn's disease	0.000671	0.0012	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Prednisone—Crohn's disease	0.000664	0.00167	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Prednisone—Crohn's disease	0.000661	0.00167	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Prednisone—Crohn's disease	0.000661	0.00167	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CCR6—Crohn's disease	0.000661	0.00118	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—TYK2—Crohn's disease	0.000649	0.00116	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CRP—Crohn's disease	0.000641	0.00114	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—JAK2—Crohn's disease	0.000619	0.0011	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Prednisone—Crohn's disease	0.000616	0.00155	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—TLR4—Crohn's disease	0.000614	0.00109	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL18—Crohn's disease	0.000605	0.00108	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Prednisone—Crohn's disease	0.0006	0.00151	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—RBX1—Crohn's disease	0.000597	0.00106	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Prednisone—Crohn's disease	0.000592	0.00149	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—ICAM1—Crohn's disease	0.000589	0.00105	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CD4—Crohn's disease	0.000587	0.00105	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTGER4—Crohn's disease	0.000582	0.00104	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Prednisone—Crohn's disease	0.000572	0.00144	CcSEcCtD
Hydroxychloroquine—Dizziness—Prednisone—Crohn's disease	0.000553	0.00139	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IL2RA—Crohn's disease	0.000537	0.000957	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Prednisone—Crohn's disease	0.000532	0.00134	CcSEcCtD
Hydroxychloroquine—Rash—Prednisone—Crohn's disease	0.000527	0.00133	CcSEcCtD
Hydroxychloroquine—Dermatitis—Prednisone—Crohn's disease	0.000527	0.00133	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—UBE2D1—Crohn's disease	0.000524	0.000934	CbGpPWpGaD
Hydroxychloroquine—Headache—Prednisone—Crohn's disease	0.000524	0.00132	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—RIPK2—Crohn's disease	0.000508	0.000905	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CRP—Crohn's disease	0.000506	0.000902	CbGpPWpGaD
Hydroxychloroquine—Nausea—Prednisone—Crohn's disease	0.000497	0.00125	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—IL3—Crohn's disease	0.000495	0.000883	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TLR4—Crohn's disease	0.000485	0.000865	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—RASGRP1—Crohn's disease	0.000479	0.000854	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—TYK2—Crohn's disease	0.000478	0.000853	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ICAM1—Crohn's disease	0.000465	0.000829	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—JAK2—Crohn's disease	0.000456	0.000813	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IFNG—Crohn's disease	0.000448	0.000798	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SOCS1—Crohn's disease	0.000434	0.000774	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD4—Crohn's disease	0.000433	0.000771	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IL6—Crohn's disease	0.000402	0.000716	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL1B—Crohn's disease	0.0004	0.000712	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TYK2—Crohn's disease	0.000378	0.000674	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SMAD3—Crohn's disease	0.000375	0.000668	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—JAK2—Crohn's disease	0.000361	0.000643	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IFNG—Crohn's disease	0.000354	0.000631	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL2RA—Crohn's disease	0.000347	0.000619	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD4—Crohn's disease	0.000342	0.00061	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—STAT3—Crohn's disease	0.000335	0.000597	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IL6—Crohn's disease	0.000318	0.000566	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL1B—Crohn's disease	0.000316	0.000563	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—STAT3—Crohn's disease	0.000265	0.000472	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TYK2—Crohn's disease	0.000245	0.000436	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.000237	0.000422	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL6—Crohn's disease	0.000234	0.000417	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—JAK2—Crohn's disease	0.000233	0.000416	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL8—Crohn's disease	0.000213	0.000379	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.000201	0.000359	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL6—Crohn's disease	0.000185	0.00033	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STAT3—Crohn's disease	0.000171	0.000305	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—FADS1—Crohn's disease	0.000157	0.00028	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GPX4—Crohn's disease	0.000147	0.000262	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GCKR—Crohn's disease	0.000142	0.000253	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6—Crohn's disease	0.00012	0.000213	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALB—Crohn's disease	4.51e-05	8.05e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTGS2—Crohn's disease	3.95e-05	7.04e-05	CbGpPWpGaD
